Issue 17, 2024
From the journal:

Nanoscale Advances

Frontiers in stimuli-responsive nanoplatforms: pioneering drug delivery in nanobiotechnology

Juan C. Cruz ORCID logo *a  and  Luis H. Reyes ORCID logo *b  

* Corresponding authors

a Department of Biomedical Engineering, Universidad de los Andes, Bogotá, Colombia
E-mail: jc.cruz@uniandes.edu.co

b Department of Chemical and Food Engineering, Universidad de los Andes, Bogotá, Colombia
E-mail: lh.reyes@uniandes.edu.co

Abstract

A graphical abstract is available for this content

Graphical abstract: Frontiers in stimuli-responsive nanoplatforms: pioneering drug delivery in nanobiotechnology

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/D4NA90074J
Article type
Editorial
First published
12 Jul 2024
This article is Open Access
Creative Commons BY license

Nanoscale Adv., 2024,6, 4272-4274

Permissions

Request permissions

Frontiers in stimuli-responsive nanoplatforms: pioneering drug delivery in nanobiotechnology

J. C. Cruz and L. H. Reyes, Nanoscale Adv., 2024, 6, 4272 DOI: 10.1039/D4NA90074J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements